Light Therapy Isn't Working? Your Genes May Explain Why.

SLC6A4 encodes the serotonin transporter, a protein that sits on the surface of serotonin-releasing neurons and vacuums serotonin back up after it does its job. This recycling is how your brain conserves serotonin and keeps the signal alive.

The 5-HTTLPR short allele variant, carried by approximately 40% of people, reduces the efficiency of this recycling process. Instead of serotonin molecules being reabsorbed into the neuron, some of them drift away and disappear. This means you need more serotonin synthesis to maintain the same signal.

Light therapy alone cannot overcome this deficiency because the problem isn’t making serotonin, it’s keeping it. You produce it, but it leaks away before it can stabilize your mood. You feel temporary relief when the light is on, then crash when it ends.

COMT breaks down dopamine, norepinephrine, and epinephrine after they’ve done their job. Think of it as the braking system for your stress and motivation circuits. If COMT works fast, these molecules clear quickly and your nervous system resets. If COMT works slowly, they linger and create a state of persistent activation.

The Val158Met variant, present in roughly 25% of people as a homozygous slow variant, reduces COMT enzyme activity by 40-60%. This means dopamine and norepinephrine stay in your synapses longer than they should. You end up with a nervous system that’s constantly in a low-level emergency, even when there’s no threat.

With slow COMT, even small stressors trigger a disproportionate adrenaline response. Your body interprets minor problems as major threats. Light therapy tries to boost serotonin to calm you down, but your dopamine and norepinephrine are still screaming.

BDNF (brain-derived neurotrophic factor) is a protein that enables your brain to form new neural connections, essentially rewiring itself away from depression. It’s the mechanism behind neuroplasticity, the process that makes therapy, meditation, and light exposure actually change your brain. Without BDNF, you can have perfect serotonin levels and still be neurologically locked in depression.

The Val66Met variant, carried by roughly 30% of people, reduces BDNF secretion and impairs activity-dependent BDNF release. This means your brain struggles to form new connections even when conditions are right. Light therapy can normalize your circadian rhythm and serotonin production, but if BDNF is compromised, your brain simply cannot rewire itself away from the depressed state.

You feel a bit better on the lamp, but the improvement plateaus. The depression pattern is too entrenched. Therapy feels less effective because your brain can’t carve new pathways as readily as it should.

TPH2 (tryptophan hydroxylase 2) catalyzes the first committed step in serotonin synthesis in the brain. It converts tryptophan, an amino acid from your diet, into 5-hydroxytryptophan, the immediate precursor to serotonin. This is the rate-limiting step, meaning it’s the bottleneck that determines how much serotonin your brain can produce no matter how much tryptophan you consume.

Variants that reduce TPH2 activity are present in roughly 20% of people and directly lower the ceiling on your maximum serotonin production. Even if light therapy stimulates your brain to make serotonin as fast as possible, you’re still working with a lower absolute capacity. It’s like trying to fill a bucket with a narrower spout.

You try light therapy and feel modest improvement, but not the transformation other people describe. You hit a ceiling. The depression lifts partially but never fully. You’re not broken, you’re just operating with a constraint on production.

MAOA breaks down serotonin, dopamine, and norepinephrine once they’ve finished their signaling job. Unlike COMT, which is slow in some people, MAOA variations go the opposite direction. The MAOA-L (low activity) variant, present in roughly 30-40% of males, causes slower degradation of these neurotransmitters. They accumulate and linger rather than being cleared.

When MAOA activity is low, neurotransmitter levels fluctuate wildly because the cleanup process can’t keep pace with the production and reuptake. You end up with boom-bust cycles of mood and motivation, alternating between overstimulation and crash. Some hours you’re wired and anxious, others you’re depleted and flat.

Light therapy tries to stabilize serotonin, but MAOA-L variants create a fundamentally unstable system. The serotonin sticks around too long, causing overstimulation, then gets mopped up aggressively, leaving you depleted.

FKBP5 regulates glucocorticoid receptor sensitivity, which determines how quickly your cortisol system resets after stress. When you encounter a stressor, your adrenals release cortisol. FKBP5 acts as a brake, making your cells less sensitive to cortisol so the stress response winds down. The rs1360780 variant impairs this process, leaving your cortisol elevated longer after stress has passed.

Roughly 30% of people carry this variant. When activated, it creates a neurobiological state where your body is primed for threat long after danger has passed. Your baseline cortisol doesn’t come down. Your nervous system stays in a low-level fight-or-flight state.

Light therapy works partly through serotonin but also through resetting your circadian rhythm, which normally helps cortisol decline in the evening. If FKBP5 is variant, your cortisol decline is blunted even at night. You lie awake or wake early. Depression deepens because the nervous system never fully relaxes.